Recent years have seen a growing movement away from animal testing and toward models that more closely replicate human physiology. This shift aims to protect animal welfare while concurrently ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Washington, DC—Last month, both the National Institutes of Health and the US Food and Drug Administration announced plans to phase out the use of animals in scientific research. The Animal Welfare ...
April 10 (Reuters) - The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...
It is difficult to recall a time when doctors and patients had trouble tracking the presence of glucose and other substances in urine and blood. Lack of sufficient measurement tools made it difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results